Hepatic failure, like platelet decrease, may be related to anti-asparaginase antibodies such as IgG and IgE, which may also form and accumulate immune complexes and could be responsible for the increased organ size in WT- and P40S-enzyme-treated groups, unlike the S206C-exposed group. The gene discussed is ASPG; the disease is liver failure.